EarliTec Diagnostics, Inc.
Developer of an FDA-cleared, tablet-based eye-tracking assessment system that captures moment-by-moment visual-attention biomarkers to support clinicians in early evaluation and monitoring of autism in young children. Combines academic research, large-scale clinical validation, regulatory authorization, and provider partnerships to produce objective, repeatable metrics for diagnostic assessment and outcome tracking.
Industries
N/A
Nr. of Employees
small (1-50)
EarliTec Diagnostics, Inc.
13895 Industrial Park Blvd, Suite 140, Plymouth, MN 55441
Patents
Systems and methods for using portable computer devices having eye-tracking capability
US-12318201-B2
View Details
Systems and methods for using portable computer devices having eye-tracking capability
US-12318201-B2
View DetailsProducts
Tablet-based eye-tracking evaluation system for pediatric autism assessment
A clinician-use tablet system that captures gaze behavior while a child views standardized video stimuli, analyzes visual-attention biomarkers, and produces standardized reports to aid diagnostic assessment and track outcomes over time.
Tablet-based eye-tracking evaluation system for pediatric autism assessment
A clinician-use tablet system that captures gaze behavior while a child views standardized video stimuli, analyzes visual-attention biomarkers, and produces standardized reports to aid diagnostic assessment and track outcomes over time.
Services
Program to qualify clinical sites for low-cost access to the assessment system and to connect families with participating evaluation locations.
Educational webinar series and on-demand content for clinicians and providers, including recorded sessions accessible after live events and optional CEU credits through third-party platforms.
Program to qualify clinical sites for low-cost access to the assessment system and to connect families with participating evaluation locations.
Educational webinar series and on-demand content for clinicians and providers, including recorded sessions accessible after live events and optional CEU credits through third-party platforms.
Expertise Areas
- Early autism assessment and monitoring
- Eye-tracking biomarker development
- Clinical validation and trial evidence generation
- Regulatory submissions and FDA authorization
Key Technologies
- Tablet-based eye-tracking
- Social visual-attention biomarkers
- High-frequency gaze sampling (~120 Hz)
- Explainable machine learning
News & Updates
Live and on-demand webinar for clinicians, researchers, and developmental assessment professionals discussing objective data in clinical decision-making. Registered participants can access the recording on-demand and may be eligible for CEU credits through a third-party platform.
Large study published in JAMA comparing eye-tracking measurements of social visual engagement to expert clinical diagnosis.
Study published in JAMA Network Open describing development and replication of objective measurements for early autism assessment.
Company article announcing FDA authorization for the tablet-based evaluation system.
Article offering practical guidance for building clinical referral networks for ABA providers.
Article providing local search optimization and marketing guidance for ABA clinics.
Live and on-demand webinar for clinicians, researchers, and developmental assessment professionals discussing objective data in clinical decision-making. Registered participants can access the recording on-demand and may be eligible for CEU credits through a third-party platform.
Large study published in JAMA comparing eye-tracking measurements of social visual engagement to expert clinical diagnosis.
Study published in JAMA Network Open describing development and replication of objective measurements for early autism assessment.
Company article announcing FDA authorization for the tablet-based evaluation system.
Article offering practical guidance for building clinical referral networks for ABA providers.
Article providing local search optimization and marketing guidance for ABA clinics.